Johnson & Johnson (JNJ)

258.39
-4.65 (-1.77%)
NYSE· Last Trade: Jul 6th, 1:29 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close263.04
Open260.23
Bid258.32
Ask258.45
Day's Range255.93 - 261.38
52 Week Range154.21 - 263.10
Volume2,765,658
Market Cap679.22B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield5.360 (2.07%)
1 Month Average Volume9,249,305

Chart

About Johnson & Johnson (JNJ)

Johnson & Johnson is a multinational corporation engaged in the development, manufacturing, and marketing of a wide range of healthcare products. The company operates through three primary segments: pharmaceuticals, medical devices, and consumer health products. Johnson & Johnson is known for its commitment to innovation in healthcare, producing a diverse array of products that include prescription medications for various diseases, sophisticated medical devices for surgical procedures, and widely recognized consumer brands for personal care and wellness. With a focus on improving health outcomes, the company aims to address the evolving needs of patients and consumers around the world. Read More

News & Press Releases

What's going on in today's session: dow jones moverschartmill.com
Via Chartmill · July 6, 2026
3 Stocks to Buy and Hold: The Long-Term Play for Your Portfoliofool.com
These three healthcare stocks provide stability, relatively high dividend yields, and consistent growth.
Via The Motley Fool · July 6, 2026
Johnson & Johnson Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Callbenzinga.com
JNJ will release its Q2 earnings on July 15, with analysts expecting earnings of $2.85 per share and revenue of $25.05 billion. Stock rose 3.6%.
Via Benzinga · July 6, 2026
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway.chartmill.com
Via Chartmill · July 6, 2026
How to Find Dividend Stocks That Won’t Blow Up, Featuring Johnson & Johnson (NYSE:JNJ)chartmill.com
Via Chartmill · June 29, 2026
Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?fool.com
Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.
Via The Motley Fool · July 3, 2026
Members of Congress Are Loading Up on Johnson & Johnson and UnitedHealth. Here's Why Retail Investors Should Pay Attention.fool.com
Politicians serve on committees that set healthcare policy, monitor government contracts, and shape regulatory frameworks.
Via The Motley Fool · July 3, 2026
Which dow jones stocks are moving on Thursday?chartmill.com
Via Chartmill · July 2, 2026
Stay informed with the top movers within the dow jones index on Thursday.chartmill.com
Via Chartmill · July 2, 2026
Which dow jones stocks are moving on Wednesday?chartmill.com
Via Chartmill · July 1, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · July 1, 2026
TechMediaBreaks – SS Innovations International, Inc. (NASDAQ: SSII) Surpasses Intuitive Surgical (NASDAQ: ISRG), Johnson & Johnson (NYSE: JNJ), Medtronic (NYSE: MDT) for Top Surgical Robotics Award
S Innovations International (NASDAQ: SSII) was named Outstanding Company at the 2026 Surgical Robotics Industry Awards, surpassing finalists:
Via Investor Brand Network · July 1, 2026
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?fool.com
Bristol Myers Squibb trades at a deep discount, while Johnson & Johnson boasts higher margins and a broader reach. How do their financials and risks stack up?
Via The Motley Fool · July 1, 2026
If a Stock Market Crash Is Coming, History Shows This Stock Will Be a Brilliant Buyfool.com
It can provide some stability during volatile times.
Via The Motley Fool · June 30, 2026
Explore the top gainers and losers within the dow jones index in today's session.chartmill.com
Via Chartmill · June 30, 2026
These 3 Dividend Stocks Could Boost Your Income This Julydividendstocks.com
Realty Income, Johnson & Johnson, and Chevron offer yields ranging from 2.2% to 5.1% in July 2026, supported by analyst buy ratings and institutional accumulation.
Via MarketBeat · June 30, 2026
Which dow jones stocks are moving on Tuesday?chartmill.com
Via Chartmill · June 30, 2026
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END
Via FinancialNewsMedia · June 30, 2026
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
Next-generation MDD drugs are driving a new era of innovation, investment, and commercial opportunity
By MarketNewsUpdates.com · Via GlobeNewswire · June 30, 2026
3 Magnificent Dividend ETFs That Could Supercharge Your Passive Incomefool.com
All three ETFs complement each other well in a portfolio.
Via The Motley Fool · June 30, 2026
This Vanguard ETF Is Built for a Market That's Finally Rotating Away From Big Techfool.com
As the megacap tech trade sputters, one attractive fund already owns what's leading instead -- and it's beating the market this year.
Via The Motley Fool · June 29, 2026
Top dow jones movers in Monday's sessionchartmill.com
Via Chartmill · June 29, 2026
3 No-Brainer Dividend Stocks to Buy Right Nowfool.com
AbbVie, J&J, and Pfizer are all reliable income plays in this choppy market.
Via The Motley Fool · June 29, 2026
Stay informed with the top movers within the dow jones index on Monday.chartmill.com
Via Chartmill · June 29, 2026
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000fool.com
Abbott Labs could rally in a downturn and has a long-term growth catalyst to boot.
Via The Motley Fool · June 28, 2026